Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.45)
Consensus Price Target: $15.94 (15.16% upside)

Current Analysts' Coverage Summary for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/7/2014ZacksReiterated RatingNeutral -> Neutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014Cantor FitzgeraldDowngradeHold -> Sell$11.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Cowen and CompanyDowngradeOutperform -> Market Perform$16.00 -> $10.50ViewTweet This Rating  Share This Rating on StockTwits
8/5/2014Leerink SwannReiterated RatingMarket Perform$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014Furey Research PartnersInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014MizuhoBoost Price TargetBuy$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2014WallachBeth CapitalInitiated CoverageHold$16.00ViewTweet This Rating  Share This Rating on StockTwits
4/30/2014JPMorgan Chase & Co.Reiterated RatingOverweight$22.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014AegisReiterated RatingBuy -> PositiveViewTweet This Rating  Share This Rating on StockTwits
4/23/2014Bank of AmericaUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BMO Capital MarketsUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Jefferies GroupLower Price TargetHold$12.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013WedbushLower Price TargetNeutral$12.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
9/17/2013Goldman SachsInitiated CoverageSellViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Janney Montgomery ScottUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
6/21/2013Credit SuisseInitiated CoverageOutperform$16.00 -> $11.31ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Morgan StanleyDowngradeOverweight -> Equal Weight$21.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2013Ladenburg ThalmannBoost Price TargetBuy$16.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/24/2012 forward)